CA Stock MarketDetailed Quotes

PRM Big Pharma Split Corp

Watchlist
  • 13.400
  • -0.100-0.74%
15min DelayMarket Closed Dec 27 16:00 ET
15.15MMarket Cap13.54P/E (TTM)

Big Pharma Split Corp Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q2)Jun 30, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q2)Jun 30, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q2)Jun 30, 2021
Assets
Cash, cash equivalents and federal funds sold
300.71%1.59M
-75.07%204.19K
-75.07%204.19K
-56.87%397.51K
-42.71%819.21K
-42.71%819.21K
50.40%921.57K
518.99%1.43M
518.99%1.43M
--612.76K
-Cash and cash equivalents
300.71%1.59M
-75.07%204.19K
-75.07%204.19K
-56.87%397.51K
-42.71%819.21K
-42.71%819.21K
50.40%921.57K
518.99%1.43M
518.99%1.43M
-34.40%612.76K
-Available for sale securities
-3.76%25.95M
7.62%25.54M
7.62%25.54M
-30.06%26.97M
-32.82%23.73M
-32.82%23.73M
17.86%38.56M
57.65%35.32M
57.65%35.32M
--32.71M
Derivative assets
-89.02%42.15K
31.75%718.24K
31.75%718.24K
108.89%383.89K
-32.95%545.14K
-32.95%545.14K
--183.77K
1,776.69%813K
1,776.69%813K
--0
Receivables
-29.40%61.51K
-99.45%77.11K
-99.45%77.11K
-37.82%87.12K
13,546.44%14M
13,546.44%14M
50.58%140.11K
-1.57%102.62K
-1.57%102.62K
-96.93%93.05K
Total assets
-0.67%27.65M
-32.13%26.53M
-32.13%26.53M
-30.07%27.83M
3.39%39.1M
3.39%39.1M
18.56%39.8M
64.89%37.81M
64.89%37.81M
31.46%33.57M
Liabilities
Derivative product liabilities
----
----
----
----
----
----
----
----
----
--539.83K
Payables
189.68%1.11M
-95.94%386.11K
-95.94%386.11K
-47.94%382.94K
1,636.21%9.51M
1,636.21%9.51M
76.76%735.6K
37.08%547.79K
37.08%547.79K
-87.07%416.16K
-Accounts payable
0.01%250.54K
-28.51%248.68K
-28.51%248.68K
-27.46%250.51K
2.60%347.84K
2.60%347.84K
14.70%345.34K
59.00%339.02K
59.00%339.02K
--301.09K
-Total tax payable
----
----
----
----
----
----
----
----
----
--0
-Other payable
548.47%858.79K
-98.50%137.43K
-98.50%137.43K
-66.07%132.43K
4,288.99%9.16M
4,288.99%9.16M
239.14%390.26K
492.27%208.77K
492.27%208.77K
-96.17%115.07K
Other liabilities
7.34%10.72M
4.50%10.3M
4.50%10.3M
-34.04%9.99M
-33.70%9.85M
-33.70%9.85M
14.70%15.14M
59.00%14.86M
59.00%14.86M
--13.2M
Total liabilities
14.08%11.83M
-44.83%10.68M
-44.83%10.68M
-34.69%10.37M
25.66%19.37M
25.66%19.37M
12.15%15.88M
58.10%15.41M
58.10%15.41M
12.64%14.16M
Shareholders'equity
Total stockholders'equity
-9.42%15.82M
-19.66%15.85M
-19.66%15.85M
-27.01%17.47M
-11.93%19.73M
-11.93%19.73M
23.24%23.93M
69.92%22.4M
69.92%22.4M
49.69%19.42M
Total equity
-9.42%15.82M
-19.66%15.85M
-19.66%15.85M
-27.01%17.47M
-11.93%19.73M
-11.93%19.73M
23.24%23.93M
69.92%22.4M
69.92%22.4M
49.69%19.42M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q2)Jun 30, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q2)Jun 30, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q2)Jun 30, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q2)Jun 30, 2021
Assets
Cash, cash equivalents and federal funds sold 300.71%1.59M-75.07%204.19K-75.07%204.19K-56.87%397.51K-42.71%819.21K-42.71%819.21K50.40%921.57K518.99%1.43M518.99%1.43M--612.76K
-Cash and cash equivalents 300.71%1.59M-75.07%204.19K-75.07%204.19K-56.87%397.51K-42.71%819.21K-42.71%819.21K50.40%921.57K518.99%1.43M518.99%1.43M-34.40%612.76K
-Available for sale securities -3.76%25.95M7.62%25.54M7.62%25.54M-30.06%26.97M-32.82%23.73M-32.82%23.73M17.86%38.56M57.65%35.32M57.65%35.32M--32.71M
Derivative assets -89.02%42.15K31.75%718.24K31.75%718.24K108.89%383.89K-32.95%545.14K-32.95%545.14K--183.77K1,776.69%813K1,776.69%813K--0
Receivables -29.40%61.51K-99.45%77.11K-99.45%77.11K-37.82%87.12K13,546.44%14M13,546.44%14M50.58%140.11K-1.57%102.62K-1.57%102.62K-96.93%93.05K
Total assets -0.67%27.65M-32.13%26.53M-32.13%26.53M-30.07%27.83M3.39%39.1M3.39%39.1M18.56%39.8M64.89%37.81M64.89%37.81M31.46%33.57M
Liabilities
Derivative product liabilities --------------------------------------539.83K
Payables 189.68%1.11M-95.94%386.11K-95.94%386.11K-47.94%382.94K1,636.21%9.51M1,636.21%9.51M76.76%735.6K37.08%547.79K37.08%547.79K-87.07%416.16K
-Accounts payable 0.01%250.54K-28.51%248.68K-28.51%248.68K-27.46%250.51K2.60%347.84K2.60%347.84K14.70%345.34K59.00%339.02K59.00%339.02K--301.09K
-Total tax payable --------------------------------------0
-Other payable 548.47%858.79K-98.50%137.43K-98.50%137.43K-66.07%132.43K4,288.99%9.16M4,288.99%9.16M239.14%390.26K492.27%208.77K492.27%208.77K-96.17%115.07K
Other liabilities 7.34%10.72M4.50%10.3M4.50%10.3M-34.04%9.99M-33.70%9.85M-33.70%9.85M14.70%15.14M59.00%14.86M59.00%14.86M--13.2M
Total liabilities 14.08%11.83M-44.83%10.68M-44.83%10.68M-34.69%10.37M25.66%19.37M25.66%19.37M12.15%15.88M58.10%15.41M58.10%15.41M12.64%14.16M
Shareholders'equity
Total stockholders'equity -9.42%15.82M-19.66%15.85M-19.66%15.85M-27.01%17.47M-11.93%19.73M-11.93%19.73M23.24%23.93M69.92%22.4M69.92%22.4M49.69%19.42M
Total equity -9.42%15.82M-19.66%15.85M-19.66%15.85M-27.01%17.47M-11.93%19.73M-11.93%19.73M23.24%23.93M69.92%22.4M69.92%22.4M49.69%19.42M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending CA Stocks
Big Five Big Five

The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.